Видео ютуба по тегу Atezolizumab

Dr. Horn on the FDA Approval of Atezolizumab Plus Bevacizumab and Chemotherapy in NSCLC
Dr. Horn on the FDA Approval of Atezolizumab Plus Bevacizumab and Chemotherapy in NSCLC
Dr. Horn Discusses Next Steps With Atezolizumab in SCLC
Dr. Horn Discusses Next Steps With Atezolizumab in SCLC
Real-world study of atezolizumab vs. pembrolizumab for advanced/metastatic UC
Real-world study of atezolizumab vs. pembrolizumab for advanced/metastatic UC
Dr. Overman on the Combination of Atezolizumab and Bevacizumab in HCC
Dr. Overman on the Combination of Atezolizumab and Bevacizumab in HCC
Dr. Pishvaian Discusses Atezolizumab Plus Bevacizumab in HCC
Dr. Pishvaian Discusses Atezolizumab Plus Bevacizumab in HCC
Atezolizumab Versus Other Immunotherapy Options
Atezolizumab Versus Other Immunotherapy Options
IMpower110: atezolizumab vs chemo in PD-L1–selected NSCLC
IMpower110: atezolizumab vs chemo in PD-L1–selected NSCLC
Adjuvant atezolizumab in NSCLC
Adjuvant atezolizumab in NSCLC
Atezolizumab and Bevacizumab Studied in Patients With Metastatic RCC
Atezolizumab and Bevacizumab Studied in Patients With Metastatic RCC
First-line atezolizumab plus chemotherapy improves survival in lung cancer patients
First-line atezolizumab plus chemotherapy improves survival in lung cancer patients
Dr. Melissa Johnson on Atezolizumab in Patients With NSCLC
Dr. Melissa Johnson on Atezolizumab in Patients With NSCLC
IMPower 010: Adjuvant Atezolizumab in NSCLC - OncTalk Lung 2023
IMPower 010: Adjuvant Atezolizumab in NSCLC - OncTalk Lung 2023
ALICE: atezolizumab + immunogenic chemotherapy in metastatic TNBC
ALICE: atezolizumab + immunogenic chemotherapy in metastatic TNBC
Dr. Wakelee on BIRCH Trial for Atezolizumab in Patients With NSCLC
Dr. Wakelee on BIRCH Trial for Atezolizumab in Patients With NSCLC
Dr. Rini on the Tolerability of Atezolizumab Plus Bevacizumab in RCC
Dr. Rini on the Tolerability of Atezolizumab Plus Bevacizumab in RCC
Atezolizumab in metastatic TNBC: Long-term clinical outcomes and biomarker analyses
Atezolizumab in metastatic TNBC: Long-term clinical outcomes and biomarker analyses
ESMO 2020 Expert Video report on atezolizumab in upfront treatment of TNBC
ESMO 2020 Expert Video report on atezolizumab in upfront treatment of TNBC